Mesenchymal stem cell (MSC)-derived secretome demonstrated therapeutic effects like
those reported after MSCs transplantation. MSC-derived secretome may avoid various side …

Introduction: The available therapeutic strategies for Parkinson's disease (PD) rely only on
the amelioration of the symptomatology of the disease, lacking neuroprotection or …

Parkinson's disease (PD) is characterized by a selective loss of dopamine (DA) neurons in
the human midbrain causing motor dysfunctions. The exact mechanism behind …

Parkinson's disease is the second most prevalent neurodegenerative disorder worldwide.
Clinically, it is characterized by severe motor complications caused by progressive …

The low regeneration potential of the central nervous system (CNS) represents a challenge
for the development of new therapeutic strategies. Mesenchymal stem cells (MSCs) have …

Research in the last decade strongly suggests that mesenchymal stem cell (MSC)-mediated
therapeutic benefits are mainly due to their secretome, which has been proposed as a …

Mesenchymal stem cells (MSCs) secretome: a good candidate for medical biotechnology?
Medical biotechnology is currently defined as the application of biotechnological tools for …

Background Over the past few years, mesenchymal stromal cells (MSCs) have attracted a
great deal of scientific attention owing to their promising results in the treatment of incurable …

Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that
results from the death of dopamine (DA) neurons. Over recent years, differentiated or …

Transplantation of stem cells, in particular mesenchymal stem cells (MSCs), stands as a
promising therapy for trauma, stroke or neurodegenerative conditions such as spinal cord or …